JP2002000198A - Composition for royal jelly preparation - Google Patents

Composition for royal jelly preparation

Info

Publication number
JP2002000198A
JP2002000198A JP2000190502A JP2000190502A JP2002000198A JP 2002000198 A JP2002000198 A JP 2002000198A JP 2000190502 A JP2000190502 A JP 2000190502A JP 2000190502 A JP2000190502 A JP 2000190502A JP 2002000198 A JP2002000198 A JP 2002000198A
Authority
JP
Japan
Prior art keywords
royal jelly
acid
composition
collagen
present
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2000190502A
Other languages
Japanese (ja)
Inventor
Masayoshi Morimoto
森本正義
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
MEDICOS CEREJA KK
Original Assignee
MEDICOS CEREJA KK
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by MEDICOS CEREJA KK filed Critical MEDICOS CEREJA KK
Priority to JP2000190502A priority Critical patent/JP2002000198A/en
Publication of JP2002000198A publication Critical patent/JP2002000198A/en
Pending legal-status Critical Current

Links

Abstract

PROBLEM TO BE SOLVED: To provide a composition for a royal jelly preparation preventing quality deterioration. SOLUTION: This composition for a royal jelly preparation, obtained by adding collagen containing at least 5% of mucopolysaccharides in an amount of >=10% to dry powder royal jelly. The composition is mixed with an excipient, a lubricant, and so on and then processed by a conventional method into the preparation.

Description

【発明の詳細な説明】DETAILED DESCRIPTION OF THE INVENTION

【0001】[0001]

【産業上の利用分野】ロイヤルゼリー製剤用組成物に関
する。
The present invention relates to a composition for royal jelly preparations.

【0002】[0002]

【従来の技術】よく知られて居るように、ロイヤルゼリ
ーは通常のハチミツとは全く異るものであり、女王蜂の
餌として巣箱の中の王台と言う部分に蓄えられているも
のである。味はやや刺激的な酸味を有し、外観は白色糊
状の流動体で、女王蜂はこれだけを食べ続けることで毎
日自分の体重と同じくらいの卵を産むことができる。
2. Description of the Related Art As is well known, royal jelly is completely different from ordinary honey, and is stored in a nest in a birdhouse as bait for a queen bee. The taste has a slightly irritating sourness and the appearance is a white paste-like fluid, and the queen bee can lay eggs of its own weight every day by continuing to eat it alone.

【0003】女王蜂は女王蜂として生まれたのではな
く、普通の蜜蜂がロイヤルゼリーを食することで体の大
きい女王蜂に成長していくことから、ロイヤルゼリー中
には多くの栄養源と、特殊な作用を有する成分のあるこ
とが推測され分析されている。
[0003] The queen bee is not born as a queen bee, but a normal bee grows into a large queen bee by eating royal jelly. Therefore, many nutrient sources and special effects are contained in royal jelly. It has been speculated that there is a component having the following.

【0004】現在わかって居るロイヤルゼリーの成分
は、ビタミンB群,パントテン酸,アセチルコリン等1
0種類のビタミンや、銅,鉄,亜鉛,マグネシウム,マ
ンガン,コバルトと言ったミネラル類、24種のアミノ
酸類,デセン酸,類パロチン,R物質と呼ばれる特有成
分の存在が報告されているが、まだすべてが判明してい
るわけではない。特に、ロイヤルゼリー中の蛋白質には
特殊な生理活性を有するものの存在が認められて居り、
例えば、推定分子量48200の蛋白質にはノルエピネ
フィリンの血管収縮作用に対する抑制効果が報告されて
居り、分後多くの生理活性物質の発見が予測されてい
る。
The components of royal jelly known at present include vitamin B group, pantothenic acid, acetylcholine and the like.
It has been reported that there are 0 kinds of vitamins, minerals such as copper, iron, zinc, magnesium, manganese, and cobalt, 24 kinds of amino acids, decenoic acid, parotin, and specific components called R substances. Not everything is known yet. In particular, the presence of proteins with special physiological activities has been recognized as proteins in royal jelly,
For example, a protein having an estimated molecular weight of 48,200 has been reported to have an inhibitory effect on the vasoconstriction of norepinephrine, and it is expected that many bioactive substances will be discovered in a minute.

【0005】また自然物中ではロイヤルゼリー中の含有
量が最も多いとされている、アセチルコリンは生命活動
を支配する脳幹に位置する視床下部に働きかけ、自律神
経のバランス保持に寄与している事も良く知られて居
る。
[0005] In addition, acetylcholine, which is considered to have the highest content in royal jelly among natural objects, acts on the hypothalamus located in the brain stem, which controls vital activities, and often contributes to maintaining the balance of autonomic nerves. It is known.

【0006】以上のようなことから、ロイヤルゼリーは
健康補助食品として、また人の健康を守る副作用の無い
天然の薬として有用視され、ゼリー状,粉末,顆粒,錠
剤,カプセル等の各種剤形で市販されている。
[0006] From the above, royal jelly is regarded as useful as a dietary supplement and as a natural medicine without side effects to protect human health, and various dosage forms such as jellies, powders, granules, tablets, capsules and the like. It is commercially available at

【0007】他方、ロイヤルゼリーは極めて安定性が悪
く、保存状態によっては容易に空気中の酸素によって酸
化され、茶褐色に変色して品質劣化を引きおこす事が観
測されている。また服用した際、胃液中の強い酸によっ
てロイヤルゼリーに含まれる有効成分の一部、特に蛋白
質やペプチドが分解されその栄養価が減少すると言う問
題があった。そこで、これらの問題を解決する為に、様
々な工夫と提案がなされている。従来、ロイヤルゼリー
の鮮度を確保する為に、 まず、巣箱中の王台に蓄え
られたロイヤルゼリーを分泌後48時間以内に採取し、
冷却保存する。
[0007] On the other hand, it has been observed that royal jelly has extremely poor stability and is easily oxidized by oxygen in the air depending on the storage condition, discoloring to brown and causing deterioration in quality. In addition, when taken, there is a problem that some of the active ingredients contained in the royal jelly, especially proteins and peptides, are degraded by the strong acid in the gastric juice, and the nutritional value is reduced. Therefore, various devices and proposals have been made to solve these problems. Conventionally, in order to ensure the freshness of royal jelly, first, the royal jelly stored in the nest in the birdhouse was collected within 48 hours after secretion,
Keep cool.

【0008】フリーズドライ法によって、熱をかけず
に水分を蒸発させ粉体化する。
By the freeze-drying method, moisture is evaporated without applying heat to form a powder.

【0009】カプセル,顆粒,錠剤と言った酸素との
接触を制限する剤形を採用する。
[0009] Dosage forms, such as capsules, granules and tablets, which limit contact with oxygen are employed.

【0010】錠剤の表面に小麦グルテンミールからア
ルコール抽出した蛋白成分をコーティングし、胃酸に強
く溶腸性の性質を与える。
[0010] The surface of the tablet is coated with a protein component extracted from wheat gluten meal with alcohol to give gastric acid a strong enteric property.

【0011】などの提案がなされている。[0011] Proposals have been made.

【0012】[0012]

【発明が解決しようとする課題】しかしながら、単に顆
粒化したりカプセル化したりしたものは、空気中におけ
る酸化を完全に防ぐことは出来ない為、長期間の保存に
耐えられないと言う欠点を有する。また服用した際、胃
酸によってロイヤルゼリー中の有効成分が分解し、その
栄養価が減少する点も問題であった。
However, a product simply granulated or encapsulated has a drawback that it cannot withstand long-term storage because oxidation in the air cannot be completely prevented. In addition, when taken, the active ingredient in the royal jelly is decomposed by stomach acid, and its nutritional value is also reduced.

【0013】而して剤型を錠剤にし、さらにその表面を
腸溶性皮膜のコーティングをほどこしたものは長期保存
にも耐え、胃液による分解も防ぐことが出来る点すぐれ
ているが、剤型が錠剤に限られること、コーティングが
何層にもわたって行われる為皮膜全体が厚くなり、主成
分分量が制限されること、技術的に微妙なテクニックを
要することなどが問題であった。
[0013] Tablets whose dosage form is further coated with an enteric coating on its surface are excellent in that they can withstand long-term storage and prevent degradation by gastric juice. However, there are problems in that the coating is performed over multiple layers, the entire film becomes thick, the amount of the main component is limited, and technically delicate techniques are required.

【0014】本発明の目的は、上記した従来技術の欠点
を解消し、長期保存によっても品質低下が少く服用して
も栄養価の損失が少い各種ロイヤルゼリー剤型用の組成
物の提案にある。
An object of the present invention is to solve the above-mentioned drawbacks of the prior art, and to propose compositions for various royal jelly preparations which have little loss of quality even after long-term storage and little loss of nutritional value even when taken. is there.

【0015】[0015]

【課題を解決するための手段】上記目的を達成する為
に、本発明者はフリーズドライしたロイヤルゼリーにム
コ多糖類を5%以上含むコラーゲン乾燥粉末を10%以
上混合して得られる組成物がロイヤルゼリー単独で使用
するよりも空気中の酸素に対しても安定であり、胃酸に
対してもロイヤルゼリーの成分を守る働きがあることを
知見し本発明を完成するに至った。
Means for Solving the Problems To achieve the above object, the present inventors have developed a composition obtained by mixing a collagen dry powder containing 5% or more of mucopolysaccharide with 10% or more of freeze-dried royal jelly. The inventors have found that they are more stable against oxygen in the air than royal jelly alone and have a function of protecting stomach acid from royal jelly components, and have completed the present invention.

【0016】本発明はロイヤルゼリー製剤の剤型として
顆粒,カプセル,錠剤のいずれの剤型を採用したとして
も、空気中の酸素による酸化を防止して長期保存を可能
ならしめ、さらに服用しても胃酸によってロイヤルゼリ
ーの成分が分解することのない組成物を与えることであ
る。
According to the present invention, even if any of granule, capsule, and tablet dosage forms are used as the dosage form of the royal jelly preparation, it is possible to prevent long-term storage by preventing oxidation by oxygen in the air, and further take the medicine. It is also to provide a composition in which the components of the royal jelly are not decomposed by stomach acid.

【0017】本発明に使用される酸性ムコ多糖類を含有
するコラーゲンは、鶏のトサカ(鶏冠)や牛の臍帯から
抽出されるものであり、含有されるムコ多糖類は分子量
100万以上のヒアルロン酸が主成分で、その他コンド
ロイチン硫酸やデルマタン硫酸を少量含む。牛や豚の皮
膚、骨髄組織から得られるコラーゲンには酸性ムコ多糖
類がほとんど含まれて居らず、本発明の目的には適さな
い。すなわち、本発明の要点としてコラーゲンのみでは
なく酸性ムコ多糖類、主としてヒアルロン酸の存在が必
要不可欠である。
The collagen containing the acidic mucopolysaccharide used in the present invention is extracted from chicken tosaka (cow crown) or bovine umbilical cord, and the contained mucopolysaccharide is a hyaluronic acid having a molecular weight of 1,000,000 or more. It is mainly composed of acids, and contains small amounts of chondroitin sulfate and dermatan sulfate. Collagen obtained from bovine and porcine skin and bone marrow tissue contains almost no acidic mucopolysaccharide and is not suitable for the purpose of the present invention. That is, not only collagen but also acidic mucopolysaccharides, mainly hyaluronic acid, is essential for the present invention.

【0018】また、乳酸菌培養から得られるバイオヒア
ルロン酸は安価で純度も高いが、コラーゲンが存在しな
いのでこれも本発明には適さない。
Although biohyaluronic acid obtained from lactic acid bacteria culture is inexpensive and has high purity, it is not suitable for the present invention because collagen is not present.

【0019】本発明組成物に関しては、ロイヤルゼリー
の劣化を防ぐと言う利点を有する以外にも、コラーゲン
及びヒアルロン酸の人体に及ぼす栄養学的効果もあわせ
持つと言う利点がある。すなわち、コラーゲンは体内の
蛋白質の1/3をしめ、細胞の結合組織として存在して
居り、皮膚,腱,骨,血管壁,歯,眼の角膜等に分布し
ている最も重要な蛋白質である。
The composition of the present invention has an advantage of preventing deterioration of royal jelly and also has an advantage of having a nutritional effect of collagen and hyaluronic acid on the human body. That is, collagen represents one third of the protein in the body, exists as connective tissue of cells, and is the most important protein distributed in skin, tendon, bone, blood vessel wall, teeth, cornea of eyes, etc. .

【0020】一方、ヒアルロン酸を含むムコ多糖類はア
セチルグルコサミンとグルクロン酸が対になって重合し
た分子量数百万の高分子体であり、非常に大きい水和力
を有しているので体内では蛋白質、特にコラーゲンと複
合体を形成して存在し、組織構造の維持や潤滑作用、保
水作用などにより身体の新陳代謝や機能調整を効率よく
行なわせることで老化を防ぐ作用が知られている。現
に、日大薬学部高橋教授の最近の研究によれば、コラー
ゲン−ムコ多糖類を多く含む食飼を与えることで、ラッ
トの老化がかなりおさえられる事が報告されている。コ
ラーゲン及びムコ多糖類の栄養学的効果については多く
の文献があり、かなり一般化されて居るのでここでは多
くは述べないが、本発明に関連する例として次の点をあ
げておきたい。
On the other hand, mucopolysaccharide containing hyaluronic acid is a polymer having a molecular weight of several million which is formed by polymerizing acetylglucosamine and glucuronic acid in pairs, and has a very large hydration power. It is known that it exists in the form of a complex with proteins, particularly collagen, and has an effect of preventing aging by efficiently performing metabolism and function adjustment of the body by maintaining a tissue structure, lubricating action, water retention action, and the like. In fact, according to a recent study by Professor Takahashi of the College of Pharmacy, Nihon University, it has been reported that feeding a diet rich in collagen-mucopolysaccharide significantly suppresses aging of rats. There is much literature on the nutritional effects of collagen and mucopolysaccharides and they are fairly generalized and will not be described much here, but the following points should be mentioned as examples relating to the present invention.

【0021】ムコ多糖類は、胃壁が自己の分泌する胃酸
によって消化されない様、たえず胃壁から分泌されつづ
けている。精神的なストレスなどが続くと交感神経の作
用により胃壁からムコ多糖類が分泌されなくなり、この
為自己の胃酸により胃壁が侵食され、いわゆる胃潰瘍と
なる。つまり、ムコ多糖類は強力な胃酸から胃壁を守る
作用を有していることが判明しているが、この事実が本
発明に至るヒントとなっている。
Mucopolysaccharides are constantly being secreted from the stomach wall so that the stomach wall is not digested by the gastric acid that it secretes. If mental stress or the like continues, mucopolysaccharides are not secreted from the stomach wall due to the action of the sympathetic nerve, and the stomach wall is eroded by its own stomach acid, resulting in a so-called gastric ulcer. In other words, mucopolysaccharide has been found to have a protective effect on the stomach wall from strong stomach acid, but this fact is a hint leading to the present invention.

【0022】以下に本発明の実施例をのべる。Hereinafter, embodiments of the present invention will be described.

【0023】[0023]

【実施例1】フリーズドライし、低温で保存しておいた
粗ロイヤルゼリー(粒度150〜200μm)100K
gに鶏冠から抽出したコラーゲン粉末(ヒアルロン酸
6.8%含有)15Kg及び賦形剤として乳糖60K
g、潤沢剤として脂肪酸エステル1Kgを混合し、これ
にエチルアルコール3リットルを加え、造粒器で造粒す
る。これを乾燥器にうつし、30〜35℃の風を送って
乾燥させる。篩過器にて整粒し、顆粒径1000μmの
顆粒を得た。本品を1gごとの分包にし、顆粒状商品と
した。また同顆粒を100mgのカプセルにつめ、カプ
セル商品とした。
Example 1 100K of crude royal jelly (particle size: 150-200 μm) freeze-dried and stored at low temperature
15 kg of collagen powder (containing 6.8% of hyaluronic acid) extracted from cockscomb and lactose 60 K as an excipient
g, 1 kg of a fatty acid ester as a lubricant, 3 liters of ethyl alcohol was added, and the mixture was granulated with a granulator. This is transferred to a drier and dried by blowing air at 30 to 35 ° C. The granules were sieved with a sieve to obtain granules having a granule diameter of 1000 μm. This product was packaged every 1 g to obtain a granular product. The granules were packed in capsules of 100 mg to give capsule products.

【0024】[0024]

【実施例2】フリーズドライした粗ロイヤルゼリー10
0Kgと鶏冠から得られたコラーゲン粉末11Kg及び
賦形剤としてコーンスターチ50Kgまた潤沢剤として
硬化大豆油2Kgを混合し、これにエチルアルコール3
Literを加え湿式造粒器を用いて造粒する。これを
乾燥器にうつし40℃以下の風を送って乾燥させる。造
粒器へネットを調整し、顆粒径1500μmの顆粒を得
た。次に打錠機を用いて200mg/個の素錠を製造し
た。
Example 2 Freeze-dried coarse royal jelly 10
0 kg, 11 kg of collagen powder obtained from a cockscomb, 50 kg of corn starch as an excipient and 2 kg of hardened soybean oil as a lubricant were mixed with ethyl alcohol 3
Liter is added and granulated using a wet granulator. This is sent to a drier and dried by sending air at 40 ° C. or lower. The net was adjusted in a granulator to obtain granules having a granule diameter of 1500 μm. Next, uncoated tablets of 200 mg / piece were produced using a tableting machine.

【0025】次にゼラチン,グラニュー糖よりなる糖衣
液10Kgを用いて糖衣がけを行い、さらにその上にカ
ルナウバロウのツヤがけを行い、ロイヤルゼリーコラー
ゲンを含む糖衣錠をした。
Next, sugar coating was carried out using 10 kg of a sugar coating liquid consisting of gelatin and granulated sugar, and carnauba wax was further applied to give a sugar-coated tablet containing royal jelly collagen.

【0026】[0026]

【実施例3】実施例1及び実施例2で得られた顆粒及び
錠剤について、安定性試験及び耐酸性試験を行った。安
定性試験は加速試験として37℃、湿度70%の条件で
行った。その結果、錠剤については水分2.0%が1ヶ
月後2.1%、2ヶ月後でも2.1%で安定であった。
また、顆粒剤については裸のままでは当然ながらすぐに
水分を吸収し不安定であったが、アルミホイール−ビニ
ルで内面コートされた分包シールに入れたものは、錠剤
と同様安定ではじめ1.3%であった水分が1ヶ月後
1.5%、2ヶ月後でも1.6%と安定であった。また
全試料につき、ケルダール法で蛋白量を測定したところ
いずれも全重量の16.0%前後の値を示し、測定開始
時と開始後で測定誤差内で一致していた。本試験は加速
試験であるので、通常の状態で保存した場合は1年〜2
年は安定であると計算された。
Example 3 The granules and tablets obtained in Example 1 and Example 2 were subjected to a stability test and an acid resistance test. The stability test was performed as an accelerated test at 37 ° C. and 70% humidity. As a result, the tablet was stable with a water content of 2.0% at 2.1% after 1 month and 2.1% even after 2 months.
Naturally, the granules were not stable because they absorbed moisture immediately when they were naked, but the ones placed in a packaging seal coated on the inside with aluminum wheel-vinyl were as stable as the tablets. The moisture content was stable at 1.5% after 1 month and 1.6% even after 2 months. When the protein content of all samples was measured by the Kjeldahl method, each showed a value of about 16.0% of the total weight, which was consistent within the measurement error at the start of the measurement and after the start. Since this test is an accelerated test, one year to two years
The year was calculated to be stable.

【0027】次に、局方一般試験法に記載されている人
口胃液を用いて耐酸性試験を行った。比較の為に、コラ
ーゲン粉末を全く含まない顆粒品を実施例1と全く同様
にして製造しテストに用いた。耐酸性の指標として、ロ
イヤルゼリー中の10−ハイドロキシ−8−2−デセン
酸の含有量変化を調べた。人口胃液100ml中に顆粒
試料10gを加え37℃で1時間ゆっくり攪拌しながら
放置したあと、ただちにこの溶液をアルカリで中和し、
試験液とした。この試験液をアルコール処理して蛋白質
を除去したあと、薄層クロマト法を用いてハイドロキシ
デセン酸を分離し、分光光度計を用いて定量についても
試験を行い、比較してみた。耐酸試験前のデセン酸含量
は、それぞれ顆料試料中1.5%、比較試料中1.4%
であった。1時間の耐酸テスト後、デセン酸含量をしら
べてみると顆粒試料では0.7%に減少していた。
Next, an acid resistance test was carried out using artificial gastric juice described in the General Tests for Pharmacopoeia. For comparison, a granule containing no collagen powder was produced in the same manner as in Example 1 and used for the test. As an index of acid resistance, a change in the content of 10-hydroxy-8-2-decenoic acid in royal jelly was examined. 10 g of a granule sample was added to 100 ml of artificial gastric juice, and the mixture was allowed to stand with gentle stirring at 37 ° C. for 1 hour. The solution was immediately neutralized with an alkali.
A test solution was used. After the test solution was treated with alcohol to remove proteins, hydroxydecenoic acid was separated by thin-layer chromatography, and quantitatively tested using a spectrophotometer and compared. The decenoic acid content before the acid resistance test was 1.5% in the condyle sample and 1.4% in the comparative sample, respectively.
Met. After one hour of acid resistance test, the decenoic acid content was examined and found to be 0.7% in the granule sample.

【0028】この結果から判るように、ムコ多糖類を含
むコラーゲンはロイヤルゼリー中の有効成分が胃酸で分
解されるのを防ぐと共に、長期間安定した品質を維持す
ることに寄与していることは明らかである。
As can be seen from the results, it is clear that the collagen containing mucopolysaccharide contributes to preventing the active ingredient in the royal jelly from being decomposed by stomach acid and maintaining stable quality for a long period of time. it is obvious.

【0029】[0029]

【発明の効果】胃液により分解されず、ロイヤルゼリー
の活性成分を保持したまま腸迄到達できる。また長期間
安定した品質を維持したまま保存できる。
EFFECT OF THE INVENTION It is not decomposed by gastric juice and can reach the intestine while maintaining the active ingredient of royal jelly. In addition, it can be stored while maintaining stable quality for a long time.

Claims (1)

【特許請求の範囲】[Claims] 【請求項1】 乾燥粉末ロイヤルゼリーとムコ多糖類
を少くとも5%以上含むコラーゲンとを混合して得られ
るロイヤルゼリー各種製剤用組成物。
1. A composition for various royal jelly preparations obtained by mixing a dry powder royal jelly and a collagen containing at least 5% of mucopolysaccharide.
JP2000190502A 2000-06-26 2000-06-26 Composition for royal jelly preparation Pending JP2002000198A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2000190502A JP2002000198A (en) 2000-06-26 2000-06-26 Composition for royal jelly preparation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2000190502A JP2002000198A (en) 2000-06-26 2000-06-26 Composition for royal jelly preparation

Publications (1)

Publication Number Publication Date
JP2002000198A true JP2002000198A (en) 2002-01-08

Family

ID=18689959

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000190502A Pending JP2002000198A (en) 2000-06-26 2000-06-26 Composition for royal jelly preparation

Country Status (1)

Country Link
JP (1) JP2002000198A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005053431A1 (en) * 2003-12-04 2005-06-16 Xebecpharma Co., Ltd. Method for producing honey powder and foods using the honey powder

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005053431A1 (en) * 2003-12-04 2005-06-16 Xebecpharma Co., Ltd. Method for producing honey powder and foods using the honey powder

Similar Documents

Publication Publication Date Title
JP2008099562A (en) Skin-beautifying oral composition
CN108991532A (en) A kind of oral skin-beautifying agent of the collagen peptide comprising separate sources
JP2023178487A (en) Joint function improvement agent
JP6127545B2 (en) Method for producing anti-obesity composition comprising complex of gallate catechin and protein and caffeine
JP6619153B2 (en) Green juice
JP2010037234A (en) Antioxidant composition containing bee larva
JP6742575B2 (en) Joint function improving composition
JP2002000198A (en) Composition for royal jelly preparation
US20230096487A1 (en) Undenatured Type II Collagen in Food and Beverage Applications and Uses Thereof
JP7040898B2 (en) Oral composition for promoting type III collagen production containing a hydrolyzed eggshell membrane component as an active ingredient
US20190231744A1 (en) Protein hydrolysates
JP2019180412A (en) Oral composition
US9492494B2 (en) Oral composition
JPH05292918A (en) Functional health food
WO2018062354A1 (en) Intestinal microbiota improving agent and intestinal microbiota improving composition that include eggshell membrane–containing powder
JPH07135923A (en) Composition for functional food
JP7104267B1 (en) Cognitive function improver
JP6744673B2 (en) Joint function improving composition
JP7421184B2 (en) Agents for increasing and/or maintaining skin moisture content and skin oil content
US20220151275A1 (en) Dietary Supplement for Gastrointestinal Inflammation and Method for Making the Same
JP3059126U (en) Capsules with royal jelly
JP2021161069A (en) Postprandial blood triglyceride increase inhibitor
JP2021192642A (en) Oral composition
JPH02227049A (en) Healthy food suppressing rise in cholesterol in blood
RU2513227C2 (en) Ingredients compositions for amberat dragees